These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10487803)

  • 1. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice.
    Wijbenga JA; Balk AH; Boomsma F; Man in 't Veld AJ; Hall C
    Eur Heart J; 1999 Oct; 20(19):1424-8. PubMed ID: 10487803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs.
    Qi W; Kjekshus H; Klinge R; Kjekshus JK; Hall C
    Acta Physiol Scand; 2000 Jun; 169(2):95-102. PubMed ID: 10848639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure.
    de Groote P; Millaire A; Pigny P; Nugue O; Racadot A; Ducloux G
    J Heart Lung Transplant; 1997 Sep; 16(9):956-63. PubMed ID: 9322147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
    Hülsmann M; Berger R; Mörtl D; Gore O; Meyer B; Pacher R
    Eur J Heart Fail; 2005 Jun; 7(4):552-6. PubMed ID: 15921794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
    Klinge R; Hystad M; Kjekshus J; Karlberg BE; Djøseland O; Aakvaag A; Hall C
    Scand J Clin Lab Invest; 1998 Dec; 58(8):683-91. PubMed ID: 10088206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure.
    Larsen AI; Hall C; Aukrust P; Aarsland T; Faris P; Dickstein K
    Am J Cardiol; 2003 Jul; 92(1):91-4. PubMed ID: 12842259
    [No Abstract]   [Full Text] [Related]  

  • 19. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.